Stories > CDR-Life's FDA Clearance for Precision Immunotherapy

CDR-Life's FDA Clearance for Precision Immunotherapy

4D Molecular Therapeutics Raises $300 Mi...

AB-2100 Phase 1/2 Trial Initiated

ADC Therapeutics Reports Financial Progr...

Aadi Bioscience Validates FYARRO® for PE...

Advancing CD70 Targeted Cancer Treatment...

Affini-T Therapeutics at J.P. Morgan Hea...